Qiagen N.V. (QGEN)

Jan 16, 2025, 4:05 PM EST - 1 day ago

QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $300 Million

Jan 15, 2025, 8:13 AM EST - 2 days ago

QIAGEN N.V. to Release Results for Q4 2024 and Hold Webcast

Jan 12, 2025, 1:05 PM EST - 5 days ago

QIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share Repurchase

Jan 10, 2025, 1:30 AM EST - 7 days ago

QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples

Jan 9, 2025, 4:05 PM EST - 8 days ago

QIAGEN secures U.S. clearance for first QIAstat-Dx mini gastrointestinal panel to support year-round outpatient care

Jan 7, 2025, 4:05 PM EST - 10 days ago

QIAGEN Supports UK Initiative to Sequence Genomes of 100,000 Newborns With Expert-Curated Genomic Content

Dec 12, 2024, 4:05 PM EST - 5 weeks ago

QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data

Dec 5, 2024, 4:05 PM EST - 6 weeks ago

QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation

Nov 28, 2024, 6:00 AM EST - 7 weeks ago

QIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing

Nov 27, 2024, 4:05 PM EST - 7 weeks ago

QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis

Nov 7, 2024, 3:58 PM EST - 2 months ago

Qiagen N.V. (QGEN) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 4:35 PM EST - 2 months ago

Diagnostics firm Qiagen reports rise in third-quarter revenue

Nov 4, 2024, 1:30 AM EST - 2 months ago

QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics

Oct 29, 2024, 2:30 AM EDT - 2 months ago

QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment

Oct 10, 2024, 4:05 PM EDT - 3 months ago

QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications

Oct 10, 2024, 7:41 AM EDT - 3 months ago

QIAGEN N.V. to release results for Q3 2024 and hold webcast

Oct 7, 2024, 4:05 PM EDT - 3 months ago

Global TB Summit 2024: QIAGEN leads the charge as tuberculosis reemerges as a leading infectious killer

Sep 30, 2024, 4:05 PM EDT - 3 months ago

QIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncology

Sep 26, 2024, 4:05 PM EDT - 4 months ago

QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays

Sep 25, 2024, 4:05 PM EDT - 4 months ago

PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samples

Sep 23, 2024, 4:05 PM EDT - 4 months ago

QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database

Sep 18, 2024, 4:05 PM EDT - 4 months ago

QIAGEN expands QIAcuity digital PCR offering with over new 100 assays via GeneGlobe platform

Sep 12, 2024, 4:05 PM EDT - 4 months ago

QIAGEN and Bio-Manguinhos/Fiocruz collaborate to enhance malaria and dengue detection in Brazil's national screening programs

Sep 4, 2024, 4:05 PM EDT - 4 months ago

QIAGEN and Lilly collaborate to support development of a QIAstat-Dx IVD panel that identifies patients at risk for developing Alzheimer's disease

Sep 3, 2024, 5:05 PM EDT - 4 months ago

QIAGEN N.V. announces conversion price of new net share settled convertible bonds

Sep 3, 2024, 11:00 AM EDT - 4 months ago

QIAGEN N.V. announces successful placement of new net share settled convertible bonds

Sep 3, 2024, 2:36 AM EDT - 4 months ago

QIAGEN N.V. launches non-US offering of net share settled convertible bonds

Aug 28, 2024, 4:05 PM EDT - 5 months ago

QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in chronic diseases

Aug 1, 2024, 3:04 PM EDT - 6 months ago

Qiagen N.V. (QGEN) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 4:06 PM EDT - 6 months ago

QIAGEN delivers solid performance and exceeds outlook for Q2 2024

Jul 2, 2024, 9:29 AM EDT - 7 months ago

QIAGEN N.V. to release results for Q2 2024 and hold webcast

Jun 27, 2024, 4:05 PM EDT - 7 months ago

QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children

Jun 17, 2024, 7:30 AM EDT - 7 months ago

QIAGEN announces 2028 strategy for solid profitable growth

Jun 13, 2024, 4:05 PM EDT - 7 months ago

QIAGEN's software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs

Jun 12, 2024, 4:05 PM EDT - 7 months ago

QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to sustainable growth

Jun 11, 2024, 4:05 PM EDT - 7 months ago

QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance

Jun 6, 2024, 4:05 PM EDT - 8 months ago

QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition period

Jun 5, 2024, 4:05 PM EDT - 8 months ago

QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobe

Jun 3, 2024, 2:00 AM EDT - 8 months ago

QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal care

May 29, 2024, 4:05 PM EDT - 8 months ago

QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine

May 23, 2024, 9:17 AM EDT - 8 months ago

Lab Instrument Industry Update - New Commercial Entrants

AKYA BNGO CTKB DHR LAB MASS OMIC

May 14, 2024, 4:05 PM EDT - 8 months ago

QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support

May 13, 2024, 2:00 AM EDT - 8 months ago

QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results

May 7, 2024, 4:05 PM EDT - 9 months ago

QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics

May 2, 2024, 4:05 PM EDT - 9 months ago

QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications

Apr 30, 2024, 3:27 PM EDT - 9 months ago

Qiagen N.V. (QGEN) Q1 2024 Earnings Call Transcript

Apr 29, 2024, 4:05 PM EDT - 9 months ago

QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance

Apr 24, 2024, 4:05 PM EDT - 9 months ago

QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance

Apr 9, 2024, 9:48 AM EDT - 10 months ago

QIAGEN N.V. to release results for Q1 2024 and hold webcast

Apr 3, 2024, 4:05 PM EDT - 10 months ago

QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024